Nettle and Cranberry Capsules for Prevention of Urinary Tract Infection
- Conditions
- Urinary Tract Infection
- Interventions
- Dietary Supplement: Nettle and Cranberry complex capsulesDietary Supplement: Placebo(starch)
- Registration Number
- NCT05880602
- Lead Sponsor
- Chung Shan Medical University
- Brief Summary
This study investigates whether the oral intake of a nettle and cranberry complex capsule may prevent recurrent urinary tract infection (rUTI). Participants will be aged between 30 - 75 years of age, with confirmed diagnosis of UTI status. The participants will be assessed for several parameters and asked to take 2 nettle and cranberry complex capsules twice daily for 8 weeks. The parameters will include international prostate symptoms score (IPSS), overactive bladder symptom score (OABSS), international consultation on incontinence questionnaire - overactive bladder (ICIQ-OAB), 3-day bladder diary (3dBD), and urine routine.
- Detailed Description
Urinary tract infections (UTIs) are one of the most common bacterial infections affecting women. UTI occurs in 50-80% of women in the general population. About one in four women with one UTI episode will go on to develop frequent recurrences.
Recurrent urinary tract infection (rUTI) is defined as repeated UTI with a frequency of at least two episodes in the preceding six months or three episodes in the past year. rUTI has been regarded as a substantial global healthcare problem.
This investigation is a randomized, double-blind study. Subjects with confirmed diagnosis of rUTI are randomly assigned to control group or treatment group, and asked to orally intake 2 capsules of either placebo or nettle and cranberry complex capsules twice daily. Participants will be assessed for parameters, including international prostate symptoms score (IPSS) (male only), overactive bladder symptom score (OABSS), international consultation on incontinence questionnaire - overactive bladder (ICIQ-OAB), 3-day bladder diary (3dBD) and urine routine. The assessments are conducted at baseline, 4 weeks, and 8 weeks after the oral intake period. The parameters are used to compare and evaluate whether the nettle and cranberry complex capsule can prevention rUTI.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
- aged between 30 and 75 years
- at least two episodes in 6 months, or at least three episodes of a UTI in 12 months.
- pregnancy women
- diabetes
- History of anatomical urogenital anomalies, urogenital tract surgery
- History of acute or chronic renal failure, nephrolithiasis
- History of intestinal diseases causing malabsorption
- Anticoagulant medication in the last month
- immunocompromise
- Known allergy or intolerance to cranberry
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment Nettle and Cranberry complex capsules Subjects will take two capsule of containing nettle and cranberry complex, twice a daily for 8 weeks. Control Placebo(starch) Subjects will take two capsule of containing starch, twice a daily for 8 weeks.
- Primary Outcome Measures
Name Time Method UTI-free duration in 8 weeks on baseline and 8 weeks Comparing the number of days from the beginning of the study to the first recurrence of UTI, and the number of days from each recurrence to the next recurrence between different treatment groups.
UTI recurrent incidence in 8 weeks 8 weeks UTI episodes during 8 weeks treatment for each subject
- Secondary Outcome Measures
Name Time Method International Prostate Symptom Score (IPSS) Change from Baseline on baseline,4 weeks and 8 weeks The IPSS questionnaire is a tool commonly used to assess the severity of LUTS, and to monitor the progress of the symptoms during treatment. Score range is 0-35, with higher scores indicating increasing symptom severity.
Overactive Bladder Symptom Score (OABSS) Change from Baseline on baseline,4 weeks and 8 weeks OABSS is a valid self-assessment questionnaire, with four questions set according to OAB syndrome to determine the severity of OAB, which includes daytime and nighttime urination frequency, urgency, and urge incontinence. Score range is 0-15, with higher scores indicating increasing symptom severity.
Bladder diary on baseline,4 weeks, and 8 weeks Assessment of number of voids, number of leakages, and post void residual.
International Consultation on Incontinence Questionnaire Overactive Bladder Score (ICIQ-OAB) Change from Baseline on baseline,4 weeks, and 8 weeks Assessment of quality of life related to the impact of overactive bladder symptoms on daily activities.
Assessment of quality of life related to the impact of overactive bladder symptoms on daily activities Assessment of quality of life related to the impact of overactive bladder symptoms on daily activities.
Trial Locations
- Locations (1)
Chung Shan Medical University Hospital
🇨🇳Taichung, Taiwan